Peter Möller Selected Research

Peter Möller Research Topics

Disease

52	Neoplasms (Cancer) 01/2024 - 03/2002
26	Lymphoma (Lymphomas) 03/2022 - 02/2002
24	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022 - 04/2003
15	Inflammation (Inflammations) 05/2024 - 03/2006
13	Hodgkin Disease (Hodgkin's Disease) 06/2021 - 11/2004
8	Carcinoma (Carcinomatosis) 01/2024 - 12/2002
8	Chordoma 03/2023 - 01/2010
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 09/2006
7	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2002
7	Wounds and Injuries (Trauma) 01/2019 - 12/2011
7	Shock 11/2017 - 02/2008
7	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013 - 02/2007
6	Adenocarcinoma 05/2024 - 06/2006
6	Hemorrhage 12/2019 - 07/2012
6	Acidosis 11/2017 - 02/2008
5	Hemorrhagic Shock 12/2021 - 07/2012
5	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019 - 09/2015
5	Hypothermia 11/2017 - 12/2011
5	Hyperoxia 11/2017 - 02/2008
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2016 - 08/2007
5	Carcinogenesis 04/2014 - 06/2006
4	Squamous Cell Carcinoma of Head and Neck 12/2022 - 03/2009
4	Sepsis (Septicemia) 01/2019 - 02/2008
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2017 - 01/2008
4	Hypoxia (Hypoxemia) 01/2017 - 10/2010
4	Peritonitis 12/2013 - 02/2008
4	Septic Shock (Toxic Shock Syndrome) 12/2013 - 02/2008
4	Reperfusion Injury 03/2013 - 02/2011
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 07/2009 - 10/2003
3	Pancreatitis 05/2024 - 01/2002
3	Adenocarcinoma of Lung 01/2024 - 01/2021
3	Disease Progression 01/2024 - 07/2009
3	Microsatellite Instability 01/2024 - 01/2023
3	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2019
3	COVID-19 01/2023 - 01/2021
3	Lung Injury 12/2021 - 12/2011
3	Infections 01/2021 - 05/2004
3	Fibrosis (Cirrhosis) 11/2018 - 10/2005
3	Obesity 01/2017 - 06/2010
3	Melanoma (Melanoma, Malignant) 07/2016 - 03/2002
3	Ischemia 03/2013 - 02/2011
3	Prostatic Neoplasms (Prostate Cancer) 03/2012 - 05/2007
2	Lung Neoplasms (Lung Cancer) 01/2024 - 07/2020
2	Giant Cell Tumors (Giant Cell Tumor) 08/2023 - 11/2021
2	Sarcoidosis (Schaumann Disease) 07/2023 - 07/2010

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2005
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2007
13	CytokinesIBA 10/2017 - 01/2002
9	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 03/2003
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 12/2002
8	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 01/2009
8	Messenger RNA (mRNA)IBA 01/2017 - 04/2003
6	Monoclonal AntibodiesIBA 03/2022 - 12/2010
6	Transcription Factors (Transcription Factor)IBA 06/2021 - 09/2010
6	3-nitrotyrosineIBA 12/2019 - 12/2013
6	Oxygen (Dioxygen)IBA 05/2016 - 02/2008
5	Sulfides (Thioethers)IBA 01/2019 - 02/2011
5	CreatinineIBA 11/2017 - 01/2009
5	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2008
5	Interleukin-6 (Interleukin 6)IBA 03/2013 - 07/2008
5	Immunoglobulins (Immunoglobulin)IBA 07/2007 - 10/2003
4	VaccinesIBA 01/2023 - 03/2002
4	AcidsIBA 09/2021 - 02/2008
4	RNA (Ribonucleic Acid)IBA 07/2021 - 06/2006
4	Janus KinasesIBA 01/2021 - 08/2009
4	AntigensIBA 12/2019 - 05/2007
4	SmokeIBA 01/2019 - 01/2015
4	NitratesIBA 03/2013 - 02/2008
4	LigandsIBA 04/2012 - 12/2002
3	Denosumab FDA Link 08/2023 - 07/2017
3	HLA-DR Antigens (HLA-DR)IBA 07/2023 - 11/2009
3	palbociclibIBA 03/2023 - 09/2015
3	Rituximab (Mabthera)FDA Link 06/2021 - 03/2013
3	ParaffinIBA 01/2020 - 03/2013
3	salicylhydroxamic acid (SHAM)IBA 01/2019 - 12/2011
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019 - 12/2013
3	LyasesIBA 01/2017 - 12/2011
3	CystathionineIBA 01/2017 - 12/2011
3	Heme Oxygenase-1IBA 01/2017 - 12/2011
3	MicroRNAs (MicroRNA)IBA 11/2016 - 11/2008
3	Caspase 3 (Caspase-3)IBA 05/2016 - 03/2009
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015 - 11/2007
3	EnzymesIBA 09/2014 - 01/2002
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2014 - 12/2011
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2013 - 01/2009
3	InterleukinsIBA 04/2013 - 01/2002
3	Erythropoietin FDA Link 03/2013 - 09/2011
3	NitritesIBA 03/2013 - 01/2009
3	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2010 - 12/2002
3	ThymidineIBA 05/2008 - 11/2006
3	SurvivinIBA 06/2006 - 10/2005
2	Cyclin D1IBA 07/2023 - 07/2011

Therapy/Procedure

28	Therapeutics 05/2024 - 01/2003
9	Drug Therapy (Chemotherapy) 05/2024 - 02/2004
8	Resuscitation 01/2019 - 07/2012
5	Artificial Respiration (Mechanical Ventilation) 01/2019 - 01/2015
4	Critical Care (Surgical Intensive Care) 12/2019 - 09/2012
3	Induced Hypothermia 11/2017 - 07/2013
2	Injections 05/2024 - 01/2019
2	Precision Medicine 01/2024 - 12/2019